Simmons Bank lessened its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 12.2% in the third quarter, Holdings Channel reports. The firm owned 9,088 shares of the pharmacy operator’s stock after selling 1,267 shares during the period. Simmons Bank’s holdings in CVS Health were worth $571,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health in the third quarter worth about $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA raised its stake in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the period. Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health during the third quarter worth $33,000. Finally, ORG Partners LLC boosted its stake in shares of CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of brokerages have commented on CVS. Barclays cut their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Truist Financial increased their target price on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research note on Friday, October 11th. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and upped their price target for the company from $59.00 to $85.00 in a report on Friday, October 4th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $68.00 price target on shares of CVS Health in a research report on Wednesday, September 4th. Nine analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $73.00.
CVS Health Stock Performance
Shares of NYSE CVS opened at $54.27 on Thursday. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market cap of $68.29 billion, a PE ratio of 13.77, a P/E/G ratio of 0.94 and a beta of 0.55. The stock has a 50 day simple moving average of $59.47 and a 200-day simple moving average of $58.88.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $2.21 earnings per share. On average, equities research analysts forecast that CVS Health Co. will post 5.44 EPS for the current year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.90%. CVS Health’s payout ratio is 67.51%.
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
- Five stocks we like better than CVS Health
- Best Stocks Under $5.00
- Rocket Lab is the Right Stock for the Right Time
- Dividend Capture Strategy: What You Need to Know
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Using the MarketBeat Dividend Yield Calculator
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.